" More Profitable To NOT Find A Cure"- FDA Commissioner SHOCKS With Cancer Profit Secrets

Marty Makary responds to whether curing cancer is profitable and explains how red tape blocks generic biologics. He details priority review vouchers, massive drug price drops, and new treatments that melt tumors, restore hearing, and target diabetes as the FDA shifts from censorship to delivering real cures.